Related Experiment Video
Updated: Jul 29, 2026

Evaluation of Cerebral Blood Flow Autoregulation in the Rat Using Laser Doppler Flowmetry
Published on: January 19, 2020
Isoflurane attenuates cAMP-mediated vasodilation in rat microvessels
K W Park1, H B Dai, E Lowenstein
1Department of Anesthesia and Critical Care, Beth Israel Hospital, Harvard Medical School, Boston, MA 02215, USA.
Insights
The inhalational anesthetic isoflurane reduces beta-adrenergic and cyclic adenosine monophosphate (cAMP)-mediated vasodilation. This impairment in blood vessel relaxation occurs downstream of adenylate cyclase activation.
Area of Science:
- Cardiovascular Physiology
- Anesthesiology
- Pharmacology
Background:
- Inhalational anesthetics like isoflurane can affect vascular function.
- Endothelium-dependent vasodilation mediated by cyclic guanosine monophosphate (cGMP) is known to be attenuated by isoflurane.
Purpose of the Study:
- To investigate the impact of isoflurane on beta-adrenergic and cyclic adenosine monophosphate (cAMP)-mediated vasodilation.
- To determine the specific site of isoflurane's inhibitory action on cAMP-dependent relaxation.
Main Methods:
- Isolated pressurized coronary arteries from Wistar rats were used.
- Vessels were preconstricted, and concentration-response curves were generated for various vasodilators in the presence or absence of 2% isoflurane.
- Agents included isoproterenol, sodium fluoride, forskolin, 8-Br-cAMP, and RO20-1724.
Main Results:
- Isoflurane significantly attenuated relaxation responses to all tested agents.
- Beta-adrenergic and cAMP-mediated vasodilation were reduced by isoflurane.
- The inhibitory effect was observed despite normal phosphodiesterase activity.
Conclusions:
- Isoflurane impairs cAMP-mediated vasodilation.
- The mechanism of impairment is located downstream of adenylate cyclase activation.
- Isoflurane does not enhance cAMP phosphodiesterase activity to cause this attenuation.
Background:
Endothelium-dependent vasodilation mediated by cGMP is known to be attenuated by the inhalational anesthetic isoflurane. The present study examines the effect of isoflurane on beta-adrenergic and cAMP-mediated vasodilation.
Methods And Results:
Fifty-three subepicardial coronary arteries (diameter, 103 +/- 13 microns) from Wistar rats were studied in vitro in a pressurized (40 mm Hg), no-flow state with use of optical density video detection system. After preconstriction of vessels with the thromboxane A2 analogue U46619 10(-6) mol/L, concentration response curves to the nonselective beta-adrenergic agonist isoproterenol, the Gs protein activator sodium fluoride, the adenylate cyclase activator forskolin, the cAMP analogue 8-Br-cAMP, or the phosphodiesterase inhibitor RO20-1724 were obtained either in the presence of absence (control) of 2% isoflurane. Relaxations to all the agents tested were significantly reduced in the presence of isoflurane compared with controls.
Conclusions:
Isoflurane attenuates cAMP-mediated vasodilation. The impairment appears to be distal to adenylate cyclase and is not due to enhancement of cAMP phosphodiesterase.
Related Concept Videos
Nitric Oxide Signaling Pathway
Smooth Muscle Contraction
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
Autoregulation of Blood Flow
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.

